Skip to content
10-K

Annual Report

REMEDENT, INC.

0001144204-17-034903

← back to feed
Filed
Jun 29, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Jun 29, 2017 20M sh
Shares Diluted FY 2017 · Mar 31, 2016 20M sh
Stockholders Equity FY 2017 · Mar 31, 2016 $2.18M
Current Liabilities FY 2017 · Mar 31, 2016 $3.43M
Current Assets FY 2017 · Mar 31, 2016 $2.86M
Total Assets FY 2017 · Mar 31, 2016 $5.7M
Eps Diluted FY 2017 · Mar 31, 2016 $0.01
Eps Basic FY 2017 · Mar 31, 2016 $0.01
Sga Expense FY 2017 · Mar 31, 2016 $1.28M
Rd Expense FY 2017 · Mar 31, 2016 $8.78K
Operating Income FY 2017 · Mar 31, 2016 $7.22K
Gross Profit FY 2017 · Mar 31, 2016 $1.95M
Cash And Equivalents FY 2017 · Mar 31, 2015 $399.15K